Michael Fossel

Michael Fossel

Company: Telocyte

Job title: President & Founder

Seminars:

Panel Discussion: Emerging Treatments for Chronic Diseases when Targeting Mitochondria– Therapeutic Avenues, Clinical Trials & Future Direction 4:00 pm

Examining the current treatment options and emerging targeted therapies How can the industry design novel therapeutic strategies for the treatment of chronic diseases when targeting mitochondria? Exploring clinical trial development and the continued impact of the pandemic on on-going clinical trialsRead more

day: Day Two

Aging Mitochondria, Aging Cells, & Human Disease 1:30 pm

Understanding how cell aging underlies age-related human disease Exploring how mitochondrial dysfunction is a prominent – although not the sole – feature of cell aging Examining the key question that still remains the cause of – the “upstream” events behind – mitochondrial dysfunction Understanding the underlying processes presents an optimal point of clinical interventionRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.